Mechanism of stimulation of osteoclastic bone resorption through Gas6/Tyro 3, a receptor tyrosine kinase signaling, in mouse osteoclasts

被引:61
作者
Katagiri, M
Hakeda, Y
Chikazu, D
Ogasawara, T
Takato, T
Kumegawa, M
Nakamura, K
Kawaguchi, H [1 ]
机构
[1] Meikai Univ, Sch Dent, Dept Oral Anat, Sakado, Saitama 3500248, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1138655, Japan
[3] Univ Tokyo, Grad Sch Med, Dept Oral & Maxillofacial Surg, Bunkyo Ku, Tokyo 1138655, Japan
关键词
D O I
10.1074/jbc.M007393200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The signaling through receptor tyrosine kinases expressed on mature osteoclasts has recently been suggested to be involved in osteoclastic bone resorption. This study investigated the mechanism and the possible physiological relevance of Gas6/Tyro 3, a receptor tyrosine kinase signaling pathway in osteoclasts in stimulating osteoclastic bone resorption using several mouse culture Systems. Gas6, expressed ubiquitously in bone cells, did not affect the differentiation or the survival of osteoclasts, but stimulated osteoclast function to form resorbed pits on a dentine slice. The expression of its receptor, Tyro 3, was seen only in mature osteoclasts among bone cells. Gas6 up-regulated the phosphorylation of cellular proteins including p42/p44 mitogen-activated protein kinase (MAPK), but not p38 or c-Jun N-terminal kinase MAPK, and increased the kinase activity:of immunoprecipitated Tyro 3 in isolated osteoclasts. The ability of Gas6 to stimulate pit formation resorbed by osteoclasts was abrogated by PD98059, a specific inhibitor of p42/p44 MAPK. In addition, the Gas6 mRNA level in bone marrow was up-regulated by ovariectomy and was reduced by estrogen replacement. These results strongly suggest that Gas6 acts directly on mature osteoclasts through activation of Tyro 3 and p42/p44 MAPK, possibly contributing to the bone loss by estrogen deficiency.
引用
收藏
页码:7376 / 7382
页数:7
相关论文
共 44 条
  • [1] PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO
    ALESSI, DR
    CUENDA, A
    COHEN, P
    DUDLEY, DT
    SALTIEL, AR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) : 27489 - 27494
  • [2] REQUIREMENT OF PP60C-SRC EXPRESSION FOR OSTEOCLASTS TO FORM RUFFLED BORDERS AND RESORB BONE IN MICE
    BOYCE, BF
    YONEDA, T
    LOWE, C
    SORIANO, P
    MUNDY, GR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (04) : 1622 - 1627
  • [3] M-CSF neutralization and Egr-1 deficiency prevent ovariectomy-induced bone loss
    Cenci, S
    Weitzmann, MN
    Gentile, MA
    Aisa, MC
    Pacifici, R
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (09) : 1279 - 1287
  • [4] Identification of Gas6 as a ligand for Mer, a neural cell adhesion molecule related receptor tyrosine kinase implicated in cellular transformation
    Chen, J
    Carey, K
    Godowski, PJ
    [J]. ONCOGENE, 1997, 14 (17) : 2033 - 2039
  • [5] Fibroblast growth factor (FGF)-2 directly stimulates mature osteoclast function through activation of FGF receptor 1 and p42/p44 MAP kinase
    Chikazu, D
    Hakeda, Y
    Ogata, N
    Nemoto, K
    Itabashi, A
    Takato, T
    Kumegawa, M
    Nakamura, K
    Kawaguchi, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (40) : 31444 - 31450
  • [6] SB-203580 IS A SPECIFIC INHIBITOR OF A MAP KINASE HOMOLOG WHICH IS STIMULATED BY CELLULAR STRESSES AND INTERLEUKIN-1
    CUENDA, A
    ROUSE, J
    DOZA, YN
    MEIER, R
    COHEN, P
    GALLAGHER, TF
    YOUNG, PR
    LEE, JC
    [J]. FEBS LETTERS, 1995, 364 (02) : 229 - 233
  • [7] DAI W, 1994, ONCOGENE, V9, P975
  • [8] A SYNTHETIC INHIBITOR OF THE MITOGEN-ACTIVATED PROTEIN-KINASE CASCADE
    DUDLEY, DT
    PANG, L
    DECKER, SJ
    BRIDGES, AJ
    SALTIEL, AR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (17) : 7686 - 7689
  • [9] FUJIMOTO J, 1994, ONCOGENE, V9, P693
  • [10] MACROPHAGE-COLONY-STIMULATING FACTOR STIMULATES SURVIVAL AND CHEMOTACTIC BEHAVIOR IN ISOLATED OSTEOCLASTS
    FULLER, K
    OWENS, JM
    JAGGER, CJ
    WILSON, A
    MOSS, R
    CHAMBERS, TJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (05) : 1733 - 1744